NO166063C - Baerebelegg til belegging av et medikament for oppnaaelse av et farmasoeytisk preparat med forlenget frigivelse. - Google Patents

Baerebelegg til belegging av et medikament for oppnaaelse av et farmasoeytisk preparat med forlenget frigivelse.

Info

Publication number
NO166063C
NO166063C NO852225A NO852225A NO166063C NO 166063 C NO166063 C NO 166063C NO 852225 A NO852225 A NO 852225A NO 852225 A NO852225 A NO 852225A NO 166063 C NO166063 C NO 166063C
Authority
NO
Norway
Prior art keywords
coating
preparation
medicament
medicine
opening
Prior art date
Application number
NO852225A
Other languages
English (en)
Norwegian (no)
Other versions
NO166063B (no
NO852225L (no
Inventor
Paul Jonathan Harrison
John Richard Langridge
Christopher John Potter
Original Assignee
Sterwin Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterwin Ag filed Critical Sterwin Ag
Publication of NO852225L publication Critical patent/NO852225L/no
Publication of NO166063B publication Critical patent/NO166063B/no
Publication of NO166063C publication Critical patent/NO166063C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
NO852225A 1984-06-04 1985-06-03 Baerebelegg til belegging av et medikament for oppnaaelse av et farmasoeytisk preparat med forlenget frigivelse. NO166063C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848414220A GB8414220D0 (en) 1984-06-04 1984-06-04 Medicaments in unit dose form

Publications (3)

Publication Number Publication Date
NO852225L NO852225L (no) 1985-12-05
NO166063B NO166063B (no) 1991-02-18
NO166063C true NO166063C (no) 1991-05-29

Family

ID=10561912

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852225A NO166063C (no) 1984-06-04 1985-06-03 Baerebelegg til belegging av et medikament for oppnaaelse av et farmasoeytisk preparat med forlenget frigivelse.

Country Status (20)

Country Link
US (1) US4806361A (da)
EP (1) EP0164959B1 (da)
JP (1) JPS611614A (da)
KR (1) KR920004094B1 (da)
AT (1) ATE73323T1 (da)
AU (1) AU573006B2 (da)
CA (1) CA1258232A (da)
DE (1) DE3585560D1 (da)
DK (1) DK164259C (da)
ES (1) ES8608863A1 (da)
FI (1) FI87990C (da)
GB (1) GB8414220D0 (da)
GR (1) GR851356B (da)
IL (1) IL75403A (da)
MX (1) MX159928A (da)
NO (1) NO166063C (da)
NZ (1) NZ212268A (da)
PH (1) PH24225A (da)
PT (1) PT80583B (da)
ZA (1) ZA854116B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5862314A (ja) * 1981-10-07 1983-04-13 Mazda Motor Corp 過給機付エンジンの吸気装置
JPS5993939A (ja) * 1982-11-19 1984-05-30 Toyota Motor Corp 内燃機関のノツキング制御装置
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
JPH01165520A (ja) * 1987-12-23 1989-06-29 Shin Etsu Chem Co Ltd 持続性製剤およびその製造方法
JPH07100665B2 (ja) * 1987-12-23 1995-11-01 信越化学工業株式会社 被覆薬剤の製造方法
US4880636A (en) * 1988-05-13 1989-11-14 Franz Robert M Film coated tablet of ranitidine HCl
US4938968A (en) * 1988-07-26 1990-07-03 Norjec Development Associates, Inc. Controlled release indomethacin
CA2007181C (en) * 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
CA2007055A1 (en) * 1989-01-06 1990-07-06 Garth Boehm Theophylline dosage form
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
US5330766A (en) * 1989-01-06 1994-07-19 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5213811A (en) * 1991-09-13 1993-05-25 Sterling Drug Inc. Oral sustained-release drug compositions
JPH05149118A (ja) * 1991-11-29 1993-06-15 Mitsubishi Motors Corp エンジンの圧縮比を変化させる方法
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
US7008668B2 (en) 1995-05-09 2006-03-07 Phoqus Pharmaceuticals Limited Powder coating composition for electrostatic coating of pharmaceutical substrates
PT824344E (pt) 1995-05-09 2005-09-30 Phoqus Pharmaceuticals Ltd Composicao de revestimento em po para revestimento electrostatico de substratos farmaceuticos
GB9623634D0 (en) 1996-11-13 1997-01-08 Bpsi Holdings Inc Method and apparatus for the coating of substrates for pharmaceutical use
FR2758461A1 (fr) * 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (fr) 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
DE60036874T2 (de) 1999-09-02 2008-06-26 Nostrum Pharmaceuticals Inc. Pellet formulierung mit gesteuerter freisetzung
GB0002305D0 (en) 2000-02-01 2000-03-22 Phoqus Limited Power material for electrostatic application
JP2002003366A (ja) * 2000-06-23 2002-01-09 Freunt Ind Co Ltd 固形薬剤用水系コーティング剤組成物
GB0407312D0 (en) 2004-03-31 2004-05-05 Phoqus Pharmaceuticals Ltd Method and apparatus for the application of powder material to substrates
EP2161036B1 (en) * 2007-06-06 2014-12-10 Asahi Kasei Chemicals Corporation Cellulose fine core particle, and method for production thereof
AU2012297569B2 (en) * 2011-08-16 2017-11-09 Baker Heart and Diabetes Institute Controlled-release formulation
JP2018500365A (ja) 2014-12-22 2018-01-11 カーディオラ ピーティーワイ リミテッド 治療方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
US3328256A (en) * 1963-05-27 1967-06-27 William E Gaunt Spherical beads and their production
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
JPS50129727A (da) * 1974-04-04 1975-10-14
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4180559A (en) * 1978-01-05 1979-12-25 Richardson-Merrell Inc. Coated 1-(2-chlorodibenzo[b,f]oxepin-10-yl)-4-methylpiperazine compositions
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
SE7813246L (sv) * 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
IL61501A (en) * 1979-11-26 1984-06-29 Sterling Drug Inc 5-(pyridinyl)-2(1h)-pyridinones,their preparation and pharmaceutical compositions containing them
US4313951A (en) * 1979-11-26 1982-02-02 Sterling Drug Inc. 3-Substituted-6-(lower-alkyl)-5-(pyridinyl)-2(1H)-pyridinones, their cardiotonic use and intermediates therefor
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3126703A1 (de) * 1981-07-07 1983-01-27 Dr. Karl Thomae Gmbh, 7950 Biberach Bromhexin-retardform und verfahren zu ihrer herstellung
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
MX7567E (es) * 1981-12-23 1989-10-27 Yamanouchi Pharma Co Ltd Procedimiento para recubrir nicardipina de accion prolongada
JPS58116414A (ja) * 1981-12-23 1983-07-11 Yamanouchi Pharmaceut Co Ltd ニカルジピン持続性製剤用球形顆粒およびその製造法
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale

Also Published As

Publication number Publication date
ES543826A0 (es) 1986-07-16
FI852235L (fi) 1985-12-05
DK164259B (da) 1992-06-01
KR920004094B1 (ko) 1992-05-25
NZ212268A (en) 1988-10-28
DK164259C (da) 1992-10-19
DE3585560D1 (de) 1992-04-16
DK247285D0 (da) 1985-06-03
GB8414220D0 (en) 1984-07-11
PT80583A (en) 1985-07-01
AU4323685A (en) 1985-12-12
EP0164959A3 (en) 1986-12-17
US4806361A (en) 1989-02-21
PH24225A (en) 1990-04-10
NO166063B (no) 1991-02-18
FI852235A0 (fi) 1985-06-04
AU573006B2 (en) 1988-05-26
DK247285A (da) 1985-12-05
JPS611614A (ja) 1986-01-07
MX159928A (es) 1989-10-06
CA1258232A (en) 1989-08-08
EP0164959B1 (en) 1992-03-11
PT80583B (pt) 1987-09-18
IL75403A (en) 1988-08-31
ZA854116B (en) 1986-01-29
ATE73323T1 (de) 1992-03-15
EP0164959A2 (en) 1985-12-18
FI87990C (fi) 1993-03-25
KR860000068A (ko) 1986-01-25
ES8608863A1 (es) 1986-07-16
NO852225L (no) 1985-12-05
GR851356B (da) 1985-11-25
FI87990B (fi) 1992-12-15

Similar Documents

Publication Publication Date Title
NO852225L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat i doseform.
Waziri Glycine therapy of schizophrenia.
ATE81287T1 (de) Am zielorgan wirkendes enterales abgabesystem.
CA2065809A1 (en) Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids
FI904341A0 (fi) Menetelmä kaksinkertaisesti päällystettyjen granulaattien valmistamiseksi
NO146456C (no) Fremgangsmaate for fremstilling av kapsellegeme, saerlig for medisindoseringskapsel
IS1858B (is) Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
DE3866033D1 (de) Arzneizubereitungen mit mikronisierten ebselen-kristallen.
NZ222107A (en) Therapeutic powder form of spray-dried acetaminophen and ethylcellulose and pharmaceutical compositions for oral administration thereof
MC2289A1 (fr) Composes heterocycliques
EP0425298A3 (en) Sustained-release preparation of basic medical agent hydrochloride
JPS58134033A (ja) 医薬組成物
Kwei et al. Regiospecific intestinal absorption of the HIV protease inhibitor L-735,524 in beagle dogs
NO891114D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
ATE169818T1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
EP0271151A3 (en) Azumolene dosage form
GB9420748D0 (en) 1,5 benzodiazepine derivatives
KR940001887A (ko) 신규 경구제형
KR19980077329A (ko) 이중층 약물 함유 제어방출성 제제
JPS62111919A (ja) プロプラノロ−ル製剤
JPS5251032A (en) Medicines of disaccharide-glutathione derivatives
Ahmed (1) In vitro and in vivo testing of a gastric retention device.(2) Development and evaluation of a new colonic delivery system
JPS57112329A (en) Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid
RU93050128A (ru) Производные цефалоспорина